150 related articles for article (PubMed ID: 2060600)
1. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
Schoemaker H; Hicks PE; Langer SZ
J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
Ishii A
Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
[TBL] [Abstract][Full Text] [Related]
7. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
Ikeda S; Oka J; Nagao T
Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
[TBL] [Abstract][Full Text] [Related]
8. Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
Melena J; Wood JP; Osborne NN
Eur J Pharmacol; 1999 Aug; 378(3):317-22. PubMed ID: 10493108
[TBL] [Abstract][Full Text] [Related]
9. Azidobutyryl clentiazem, a new photoactivatable diltiazem analog, labels benzothiazepine binding sites in the alpha 1 subunit of the skeletal muscle calcium channel.
Watanabe T; Kalasz H; Yabana H; Kuniyasu A; Mershon J; Itagaki K; Vaghy PL; Naito K; Nakayama H; Schwartz A
FEBS Lett; 1993 Nov; 334(3):261-4. PubMed ID: 8243628
[TBL] [Abstract][Full Text] [Related]
10. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
11. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
Schoemaker H; Langer SZ
Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
[TBL] [Abstract][Full Text] [Related]
12. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
13. Polyamines allosterically modulate [3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain.
Schoemaker H
Eur J Pharmacol; 1992 Feb; 225(2):167-9. PubMed ID: 1312941
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation.
Dumont L; Chen H; Daloze P; Xu D; Garceau D
Transplantation; 1993 Jul; 56(1):181-4. PubMed ID: 8333040
[TBL] [Abstract][Full Text] [Related]
15. High-affinity binding of [3H]DTZ323 to the diltiazem-binding site of L-type Ca2+ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 2003 Apr; 466(1-2):63-71. PubMed ID: 12679142
[TBL] [Abstract][Full Text] [Related]
16. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
Zobrist RH; Mecca TE
J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
[TBL] [Abstract][Full Text] [Related]
17. Drotaverine interacts with the L-type Ca(2+) channel in pregnant rat uterine membranes.
Tömösközi Z; Finance O; Arányi P
Eur J Pharmacol; 2002 Aug; 449(1-2):55-60. PubMed ID: 12163106
[TBL] [Abstract][Full Text] [Related]
18. Interactions of calmodulin antagonists with calcium antagonists binding sites.
Schaeffer P; Lugnier C; Stoclet JC
Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
[TBL] [Abstract][Full Text] [Related]
19. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
20. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]